Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar;23(3):311-324.
doi: 10.1007/s11864-022-00959-z. Epub 2022 Mar 4.

Pathogenesis and Amelioration of Radiation-Induced Oral Mucositis

Affiliations
Review

Pathogenesis and Amelioration of Radiation-Induced Oral Mucositis

Charles T Lee et al. Curr Treat Options Oncol. 2022 Mar.

Abstract

Oral mucositis (OM) causes significant detriment to patient quality of life. Despite advances in RT, chemotherapy, and surgery for HNC which have led to improved local control and survival, management of certain toxicities such as OM have not kept pace. Numerous strategies have emerged with demonstrable benefit in preventing severe OM. However, ones which are not only effective, but practical and affordable to implement are rare. For example, infusion of growth factors or free radical scavengers, and daily treatment of intra-oral sites with lasers are supported by high-quality evidence but have not become widely adopted. It falls to familiarity of the physician with the available preventative measures and ultimately, patient preference in accepting which strategies for OM amelioration are used. In this review, we present a pathophysiological-based review of prevention techniques available for reducing the incidence and duration of severe OM.

Keywords: Antiseptic; Growth factors; Head and neck cancer; Mouth rinse; Mucositis; Oral; Oral hygiene; Oropharynx; Photobiomodulation; Probiotic; Radiotherapy; Reactive oxygen species; Toxicity.

PubMed Disclaimer

Conflict of interest statement

Funding and/or Conflicts of Interests

The authors have no funding sources and no conflicts of interests to disclose for this review.

Figures

Figure 1.
Figure 1.
Steps in oral mucositis pathogenesis and the interventional strategies which target them are summarized in this figure. Growth factors and alternate systemic therapies are not shown.

Similar articles

Cited by

References

    1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71:7–33. - PubMed
    1. Raber-Durlacher JE, Elad S, Barasch A. Oral mucositis. Oral Oncol. 2010;46:452–6. - PubMed
    1. Cinausero M, Aprile G, Ermacora P, Basile D, Vitale MG, Fanotto V, et al. New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury. Front Pharmacol. 2017;8:354. - PMC - PubMed
    1. Shaikh T, Handorf EA, Murphy CT, Mehra R, Ridge JA, Galloway TJ. The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2016;96:967–75. - PMC - PubMed
    1. Elting LS, Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys. 2007;68:1110–20. - PubMed